As we reach the half-way point in the timeline to accomplish the UN Sustainable Development Goals, it is important to look at new approaches to accelerate progress. With attainment of 12 of the 17 SDGs being slowed or reversed by AMR, closer examination of the impact of AMR is needed. 

This webinar examines the wide-spread and negative impact of AMR on attainment of the SDGs, including SDG-3 (Good Health & Wellbeing), SDG-2 (Zero Hunger) and SDG-8 (Decent Work & Economic Growth). It will also explore policy considerations, through a One Health lens, that address escalating AMR rates while limiting its impact on the SDGs. 

The format of this 1-hour webinar will be a moderator-run Q&A, with additional questions from the audience. The moderator will be Dr. Susan Rogers Van Katwyk (Managing Director, AMR Policy Accelerator at Global Strategy Lab). Panelists include Dr. Viviana Muñoz Tellez (Programme Coordinator, Health, Intellectual Property and Biodiversity Programme, South Centre), Dr. Sujith J Chandy (Executive Director, ICARS) and Anand Balachandran (Unit Head, National Action Plans & Monitoring Unit, AMR Division, World Health Organization). 

Moderator and Panelists

Dr. Susan Rogers Van Katwyk is Managing Director of the AMR Policy Accelerator, an Adjunct Professor with the School of Global Health at York University and an epidemiologist with significant experience engaging policymakers and mobilizing interdisciplinary teams to improve policy implementation, evaluation and decision making at national and international levels. Susan also holds leadership positions with the WHO Collaborating Centre on Global Governance of Antimicrobial Resistance and the International Network for AMR Social Science (INAMRSS). 


Anand Balachandran is the Unit Head, National Action Plans & Monitoring Unit with the Antimicrobial Resistance (AMR) Division at World Health Organization. Anand has worked with WHO for 20+ years, and also has experience in the areas of hunger relief, and conflict management. He has expertise in strategic planning, implementing complex multi-stakeholder projects, managing global partnerships, and leading global political advocacy initiatives. He holds an MA in International Law and Diplomacy from the Fletcher School at Tufts University and an MA in Sociology from Georgia State University.

Dr. Sujith J Chandy is Executive Director at ICARS (International Centre for Antimicrobial Resistance Solutions) and prior to this role, Senior Professor, Department of Pharmacology & Clinical Pharmacology at Christian Medical College, Vellore, India and Director of ReAct Asia Pacific. His PhD was awarded from Karolinska Institutet, Stockholm at the Department of Global for his work on antibiotic use and AMR. Dr. Chandy is a resource person at many international forums and is a member of the WHO Strategic and Technical Advisory Group on AMR. 

Dr. Viviana Muñoz Tellez is the Programme Coordinator of the Health, Intellectual Property and Biodiversity (HIPB) Programme of the South Centre, an intergovernmental think tank of 55 developing countries. As of 2006, Dr. Muñoz leads the HIPB team providing policy-oriented research, expert advice and technical assistance activities to developing countries and runs various projects on AMR. She holds a Doctorate degree on management of technology from the École Polytechnique of Lausanne (EPFL), Switzerland and a Master’s degree in Development Management from the London School of Economics (LSE).